Global Solutions For Infectious Diseases
- Assets
- $528.1k
- Revenue
- $961.7k
- Investments
- $0.0
- Employees
- 6
- Location
- Lafayette, CA
- Founding
- 11/2005
- Data as of
- 12/2022
- EIN
- 20-0941177
Organization Overview
Global Solutions For Infectious Diseases is located in Lafayette, CA. The organization was established in 2005. According to its NTEE Classification (H81) the organization is classified as: AIDS Research, under the broad grouping of Medical Research and related organizations. As of 12/2022, Global Solutions For Infectious Diseases employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Global Solutions For Infectious Diseases is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Global Solutions For Infectious Diseases generated $961.7k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 8 years, the organization has seen revenues fall by an average of (6.6%) each year. All expenses for the organization totaled $1.0m during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (6.4%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF GSID IS TO EXPAND THE DEVELOPMENT OF LOW-COST EFFECTIVE TOOLS FOR THE DIAGNOSIS AND PREVENTION OF INFECTIOUS DISEASES AFFLICTING LESS DEVELOPED COUNTRIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
AIDSVAX HIV VACCINE PROGRAM:GSID'S ONLY PROGRAM SERVICE AREA IN 2022 WAS SERVING AS MANUFACTURING AND PRODUCT SPONSOR FOR ITS AIDSVAX VACCINE AND MAINTAINING A MANUFACTURING REAGENTS REPOSITORY AND CLINICAL TRIAL (PREVIOUSLY CONDUCTED) DATABASES. DURING 2022, GSID COMPLETED THE PRODUCT STABILITY TESTING NECESSARY TO QUALIFY ITS VACCINE PRODUCT FOR USE IN HUMAN CLINICAL TRIALS. SINCE 2020, THE VACCINE HAS BEEN EVALUATED IN AN ONGOING PHASE 2B CLINICAL TRIAL CENTERED IN THREE SUB-SAHARAN AFRICAN COUNTRIES. FUNDING FOR GSID'S ACTIVITIES IN 2022 AND IN PRIOR YEARS WAS PROVIDED BY THE HENRY M. JACKSON FOUNDATION (BETHESDA, MD) AND THE IMPERIAL COLLEGE, LONDON (UNITED KINGDOM), THE SPONSOR OF THE ABOVEMENTIONED CLINICAL TRIAL.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Carter A Lee Executive Director | OfficerTrustee | 40 | $192,000 |
Faruk M Sinangil Board Member | Trustee | 20 | $96,000 |
Dr Seung-Il Shin Board Member | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $961,139 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $961,139 |
| Total Program Service Revenue | $0 |
| Investment income | $544 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $961,683 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $636,000 |
| Compensation of current officers, directors, key employees. | $63,600 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $23,040 |
| Other employee benefits | $86,864 |
| Payroll taxes | $46,537 |
| Fees for services: Management | $2,900 |
| Fees for services: Legal | $33,129 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $88,222 |
| Advertising and promotion | $0 |
| Office expenses | $9,091 |
| Information technology | $1,374 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $3,805 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $71,952 |
| All other expenses | $150 |
| Total functional expenses | $1,042,834 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $439,848 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $88,260 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $528,108 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $5,760 |
| Total liabilities | $5,760 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $522,348 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $528,108 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Global Strategies Albany, CA | $2,105,092 | $1,256,028 |
Global Solutions For Infectious Diseases Lafayette, CA | $528,108 | $961,683 |
Simmaron Research Inc Incline Village, NV | $250,197 | $297,373 |
Southern Nevada Aids Research & Education Society Las Vegas, NV | $3,951 | $206,563 |
Mama Makeka House Of Hope Fresno, CA | $102,516 | $0 |
Seeds Of Empowerment Corporation San Jose, CA | $11,517 | $0 |